Metabolic myopathies: A clinical approach; part II

Pediatric Neurology

Volumn 22, Issue 3, 2000, Pages 171-181

  Darras, Basil T ^a   Friedman, Neil R ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE MONOPHOSPHATE DEAMINASE; BRANCHED CHAIN AMINO ACID; CARNITINE; FRUCTOSE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLUCOSE; GLYCOGEN PHOSPHORYLASE B; LACTATE DEHYDROGENASE; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE MUTASE; PHOSPHORYLASE;

CARDIOMYOPATHY; CARNITINE DEFICIENCY; DECISION MAKING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME DEFICIENCY; FATTY ACID OXIDATION; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE 2; GLYCOGEN STORAGE DISEASE TYPE 3; GLYCOGEN STORAGE DISEASE TYPE 4; GLYCOGEN STORAGE DISEASE TYPE 5; GLYCOGEN STORAGE DISEASE TYPE 7; GLYCOGEN STORAGE DISEASE TYPE 8; HEPATIC ENCEPHALOPATHY; HUMAN; LIPID METABOLISM; METABOLIC DISORDER; MYOPATHY; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW;

GLYCOGEN STORAGE DISEASE; HUMANS; LIPID METABOLISM, INBORN ERRORS; METABOLISM, INBORN ERRORS; MITOCHONDRIAL MYOPATHIES; MUSCULAR DISEASES; SYNDROME;

EID: 0034015094     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00122-8     Document Type: Review

References (154)

1. Griggs R., Mendell J., Miller R. Metabolic myopathies. Griggs R., Mendell J., Miller R. Evaluation and treatment of myopathies. 1995;247-293 FA Davis, Philadelphia.
2. Heilmeyer L. Molecular basis of signal integration in phosphorylase kinase. Biochim Biophys Acta. 1094:1991;168-174.
3. DiMauro S., Tsujino S. Nonlysosomal glycogenoses. Engel A., Banker B. Myology. 1994;1554-1576 McGraw-Hill, New York.
4. Jones T.A., da Cruz e Silva E.F., Spurr N.K., Sheer D., Cohen P.T. Localisation of the gene encoding the catalytic gamma subunit of phosphorylase kinase to human chromosome bands 7p12-q21. Biochim Biophys Acta. 1048:1990;24-29.
5. Francke U., Darras B.T., Zander N.F., Kilimann M.W. Assignment of human genes for phosphorylase kinase subunits alpha (PHKA) to Xq12-q13 and beta (PHKB) to 16q12-q13. Am J Hum Genet. 45:1989;276-282.
6. Davidson J.J., Ozcelik T., Hamacher C., Willems P.J., Francke U., Kilimann M.W. cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X- linked liver glycogenosis. Proc Natl Acad Sci U S A. 89:1992;2096-2100.
7. Sahin G., Gunger T., Rettwitz-Volk W., et al. Infantile muscle phosphorylase deficiency. A case report. Neuropediatrics. 29:1998;48-50.
8. Van der Berg I., Berger R. Phosphorylase b kinase deficiency in man a review . J Inherit Metab Dis. 13:1990;442-451.
9. Abarbanel J.M., Bashan N., Potashnik R., Osimani A., Moses S.W., Herishanu Y. Adult muscle phosphorylase "b" kinase deficiency. Neurology. 36:1986;560-562.
10. Servidei S., Metlay L.A., Chodosh J., DiMauro S. Fatal infantile cardiopathy caused by phosphorylase b kinase deficiency. J Pediatr. 113:1988;82-85.
11. Lebo R.V., Gorin F., Fletterick R.J., et al. High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11. Science. 225:1984;57-59.
12. Chui L., Munsat T. Dominant inheritance of McArdle syndrome. Arch Neurol. 33:1976;636-641.
13. Schmidt B., Servidei S., Gabbai A.A., Silva A.C., de Sousa Bulle de Oliveira A., DiMauro S. McArdle's disease in two generations Autosomal recessive transmission with manifesting heterozygote . Neurology. 37:1987;1558-1561.
14. Papadimitriou A., Manta P., Divari R., Karabetsos A., Papadimitriou E., Bresolin N. McArdle's disease Two clinical expressions in the same pedigree . J Neurol. 237:1990;267-270.
15. Tsujino S., Shanske S., DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med. 329:1993;241-245.
16. Kubisch C., Wicklein E.M., Jentsch T.J. Molecular diagnosis of McArdle disease Revised genomic structure of the myophosphorylase gene and identification of a novel mutation . Hum Mutat. 12:1998;27-32.
17. McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci. 10:1951;13-35.
18. DiMauro S., Bresolin N. Phosphorylase deficiency. Engel A., Banker B. Myology. 1986;1585-1601 McGraw-Hill, New York.
19. DiMauro S., Hartlage P. Fatal infantile form of muscle phosphorylase deficiency. Neurology. 28:1978;1124-1129.
20. Milstein J., Herron T., Haas J. Fatal infantile muscle phosphorylase deficiency. J Child Neurol. 4:1989;186-188.
21. Gospe S.M. Jr, El-Schahawi M., Shanske S., et al. Asymptomatic McArdle's disease associated with hyper-creatine kinase-emia and absence of myophosphorylase. Neurology. 51:1998;1228-1229.
22. Argov Z., Bank W. Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Ann Neurol. 30:1991;90-97.
23. Servidei S., Shanske S., Zeviani M., Lebo R., Fletterick R., DiMauro S. McArdle's disease Biochemical and molecular genetic studies . Ann Neurol. 24:1988;774-781.
24. McConchie S.M., Coakley J., Edwards R.H., Beynon R.J. Molecular heterogeneity in McArdle's disease. Biochim Biophys Acta. 1096:1990;26-32.
25. MacLean D., Vissing J., Vissing S.F., Haller R.G. Oral branched-chain amino acids do not improve exercise capacity in McArdle's disease. Neurology. 51:1998;1456-1459.
26. Slonim A., Goans P. Myopathy in McArdle's syndrome. Improvement with a high protein diet. N Engl J Med. 312:1985;355-359.
27. Van Keuren M., Drabkin H., Hart I., et al. Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody. Hum Genet. 74:1986;34-40.
28. Howard T., Akots G., Bowden D. Physical and genetic mapping of the muscle phosphofructokinase gene (PFKU) Reassignment to human chromosome 129 . Genomics. 34:1996;122-127.
29. Vora S., Miranda A.F., Hernandez E., Francke U. Regional assignment of the human gene for platelet-type phosphofructokinase (PFKP) to chromosome 10p Novel use of polyspecific rodent antisera to localize human enzyme genes . Hum Genet. 63:1983;374-379.
30. Nakajima H., Noguchi T., Yamasaki T., Kono N., Tanaka T., Tarui S. Cloning of human muscle phosphofructokinase cDNA. FEBS Lett. 223:1987;113-116.
31. DiMauro S., Miranda A.F., Sakoda S., et al. Metabolic myopathies. Am J Med Genet. 25:1986;635-651.
32. Tarui S., Okuno G., Ikura Y. Phosphofructokinase deficiency in skeletal muscle A new type of glycogenosis . Biochem Biophys Res Commun. 19:1965;517-523.
33. Layzer R., Rowland L., Ranney H. Muscle phosphofructokinase deficiency. Arch Neurol. 17:1967;512-523.
34. Rowland L., DiMauro S., Layzer R. Phosphofructokinase deficiency. Engel A., Banker B. Myology. 1986;1603-1617 McGraw-Hill, New York.
35. Amit R., Bashan N., Abarbanel J.M., Shapira Y., Sofer S., Moses S. Fatal familial infantile glycogen storage disease Multisystem phosphofructokinase deficiency . Muscle Nerve. 15:1992;455-458.
36. Haller R., Lewis S. Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med. 324:1991;364-369.
37. Mineo I., Kono N., Hara N., et al. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII. N Engl J Med. 317:1987;75-80.
38. Danon M.J., Stirling D., Manaligod J.R., Schliselfeld L.H. Fatal infantile glycogen storage disease Deficiency of phosphofructokinase and phosphorylase b kinase . Neurology. 31:1981;1303-1307.
39. Guibaud P., Carrier H., Mathieu M., et al. [Familial congenital muscular dystrophy caused by phosphofructokinase deficiency.]. Arch Fr Pediatr. 35:1978;1105-1115.
40. Pastoris O., Dossena M., Vercesi L., et al. Muscle phosphofructokinase deficiency in a myopathic child with severe mental retardation and aplasia of cerebellar vermis. Childs Nerv Syst. 8:1992;237-241.
41. Servidei S., Bonilla E., Diedrich R.G. Fatal infantile form of muscle phosphofructokinase deficiency. Neurology. 36:1986;1465-1470.
42. Swoboda K.J., Specht L., Jones H.R., Shapiro F., DiMauro S., Korson M. Infantile phosphofructokinase deficiency with arthrogryposis Clinical benefit of a ketogenic diet . J Pediatr. 131:1997;932-934.
43. Kahn A., Etiemble J., Meienhofer M.C., Bovin P. Erythrocyte phosphofructokinase deficiency associated with an unstable variant of muscle phosphofructokinase. Clin Chim Acta. 61:1975;415-419.
44. Bonilla E., Schotland D. Histochemical diagnosis of muscle phosphofructokinase deficiency. Arch Neurol. 22:1970;8-12.
45. Hays A.P., Hallett M., Delfs J., et al. Muscle phosphofructokinase deficiency Abnormal polysaccharide in a case of late-onset myopathy . Neurology. 31:1981;1077-1086.
46. Kukita A., Yoshida M.C., Sakakibara M., Mukai T., Hori K. Molecular gene mapping of the structural gene for human aldolase A (ALDOA) to chromosome 22. (abstract) Cytogenet Cell Genet. 40:1985;674.
47. Serero S., Maire P., Van Cong N., et al. Localization of the active gene of aldolase on chromosome 16, and two aldolase A pseudogenes on chromosomes 3 and 10. Hum Genet. 78:1988;167-174.
48. Kreuder J., Borkhardt A., Repp R., et al. Brief report Inherited metabolic myopathy and hemolysis due to a mutation in aldolase A . N Engl J Med. 334:1996;1100-1104.
49. Chen Y.T., He J.K., Ding J.H., Brown B.I. Glycogen debranching enzyme Purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease . Am J Hum Genet. 41:1987;1002-1015.
50. Yang-Feng T.L., Zheng K., Yu J., Yang B.Z., Chen Y.T., Kao F.T. Assignment of the human glycogen debrancher gene to chromosome 1p21. Genomics. 13:1992;931-934.
51. Yang B.Z., Ding J.H., Enghild J.J., Bao Y., Chen Y.T. Molecular cloning and nucleotide sequence of cDNA encoding human muscle glycogen debranching enzyme. J Biol Chem. 267:1992;9294-9299.
52. Parvari R., Shen J., Hershkovitz E., Chen Y.T., Moses S.W. Two new mutations in the 3 coding region of the glycogen debranching enzyme in a glycogen storage disease type IIIa Ashkenazi Jewish patient. J Inherit Metab Dis. 21:1998;141-148.
53. Chen Y.T. A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12->G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet. 104:1999;111-112.
54. Shen J., Liu H.M., McConkie-Rosell A., Chen Y.T. Prenatal diagnosis and carrier detection for glycogen storage disease type III using polymorphic DNA markers. Prenat Diagn. 18:1998;61-64.
55. Brown B.I. Debranching and branching enzyme deficiencies. Engel A., Banker B. Myology. 1986;1653-1661 McGraw-Hill, New York.
56. Murase T., Ikeda H., Muro T., et al. Myopathy associated with type III glycogenosis. J Neurol Sci. 20:1973;287-295.
57. Moses S.W., Gadoth N., Bashan N., Ben-David E., Slonim A., Wanderman K.L. Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand. 75:1986;289-296.
58. Brunberg J., McCormick W., Schochet S. Type III glycogenosis An adult with diffuse weakness and muscle wasting . Arch Neurol. 25:1971;171-178.
59. Ugawa Y., Inoue K., Takemura T., Iwamasa T. Accumulation of glycogen in sural nerve axons in adult-onset type III glycogenosis. Ann Neurol. 19:1986;294-297.
60. Fernandes J. The glycogen storage diseases. Fernandes J., Saudubray J.-M., Tada K. Inborn metabolic diseases. 1990;69-88 Springer-Verlag, Berlin.
61. Slonim A.E., Weisberg C., Benke P., Evans O.B., Burr I.M. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol. 11:1982;420-422.
62. Servidei S., Riepe R.E., Langston C., et al. Severe cardiopathy in branching enzyme deficiency. J Pediatr. 111:1987;51-56.
63. Ferrans V.J., Hibbs R.G., Walsh J.J., Burch G.E. Cardiomyopathy, cirrhosis of the liver and deposits of a fibrillar polysaccharide. Report of a case with histochemical and electron microscopic studies. Am J Cardiol. 17:1966;457-469.
64. Selby R., Starzl T.E., Yunis E., Brown B.I., Kendall R.S., Tzakis A. Liver transplantation for type IV glycogen storage disease. [see comments] N Engl J Med. 324:1991;39-42.
65. Meera Khan P., Westerveld A., Grzeschik K.H., Deys B.F., Garson O.M., Siniscalco M. X-linkage of human phosphoglycerate kinase confirmed in man-mouse and man-Chinese hamster somatic cell hybrids. Am J Hum Genet. 23:1971;614-623.
66. Sugie H., Sugie Y., Ito M., Iukuda T. A novel missense mutation (837T->C) in the phosphoglycerate kinase gene of a patient with a myopathic form of phosphoglycerate kinase deficiency. J Child Neurol. 13:1998;95-97.
67. DiMauro S., Miranda A., Khan S. Human muscle phosphoglycerate mutase deficiency A newly discovered metabolic myopathy . Science. 212:1981;1277-1279.
68. Sugie H., Sugie Y., Nishida M., et al. Recurrent myoglobinuria in a child with mental retardation Phosphoglycerate kinase deficiency . J Child Neurol. 4:1989;95-99.
69. Rosa R., George C., Fardeau M., Calvin M.C., Rapin M., Rosa J. A new case of phosphoglycerate kinase deficiency PGK creteil associated with rhabdomyolysis and lacking hemolytic anemia . Blood. 60:1982;84-91.
70. Valentine W.N., Hsieh H., Paglia D.E., et al. Hereditary hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. N Engl J Med. 280:1960;528-534.
71. DiMauro S., Dalakas M., Miranda A. Phosphoglycerate kinase deficiency Another cause of recurrent myoglobinuria . Ann Neurol. 13:1983;11-19.
72. Edwards Y.H., Sakoda S., Schon E., Povey S. The gene for human muscle-specific phosphoglycerate mutase, PGAM2, mapped to chromosome 7 by polymerase chain reaction. Genomics. 5:1989;948-951.
73. Tsujino S., Sakoda S., Mizuno R., et al. Structure of the gene encoding the muscle-specific subunit of human phosphoglycerate mutase. J Biol Chem. 264:1989;15334-15337.
74. Junien C., Despoisse S., Turleau C., de Grouchy J., Bucher T., Fundele R. Assignment of phosphoglycerate mutase (PGAMA) to human chromosome 10. Regional mapping of GOT1 and PGAMA to subbands 10q26.1 (or q25.3). Ann Genet. 25:1982;25-27.
75. Tsujino S., Shanske S., Sakoda S., Fenichel G., DiMauro S. The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency. Am J Hum Genet. 52:1993;472-477.
76. Servidei S., DiMauro S. Disorders of glycogen metabolism of muscle. Neurol Clin. 7:1989;159-178.
77. Kanno T., Sudo K., Takeuchi I., et al. Hereditary deficiency of lactate dehydrogenase M-subunit. Clin Chim Acta. 108:1980;267-276.
78. Bryan W., Lewis S.F., Bertocci L., et al. Muscle lactate dehydrogenase deficiency A disorder of anaerobic glycogenolysis associated with exertional myoglobinuria . (abstract) Neurology. 40:1990;203.
79. Engel A., Hirschhorn R. Acid maltase deficiency. Engel A., Banker B. Myology. 1994;1533-1553 McGraw-Hill, New York.
80. Martiniuk F., Mehler M., Tzall S., Meredith G., Hirschhorn R. Sequence of the cDNA and 5′-flanking region for human acid alpha-glucosidase, detection of an intron in the 5′ untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences. DNA Cell Biol. 9:1990;85-94.
81. Huie M.L., Shanske A.L., Kasper J.S., Marion R.W., Hirschhorn R. A large Alu-mediated deletion, identified by PCR, as the molecular basis for glycogen storage disease type II (GSDII). Hum Genet. 104:1999;94-98.
82. Pompe J. Over idiopatische hypertrophie van het hart. Ned Tijdschr Geneeskd. 76:1932;304-311.
83. Tein I. Metabolic myopathies. Semin Pediatric Neurol. 3:1996;59-98.
84. DiMauro S., Tonin P., Servidei S. Metabolic myopathies. Rowland L., DiMauro S. Handbook of clinical neurology. 1992;479-526 Elsevier, Amsterdam, The Netherlands.
85. Kurz D., Aguzzi A., Scherer T.A. Decompensated cor pulmonale as the first manifestation of adult-onset myopathy. Respiration. 65:1998;317-319.
86. Isaacs H., Savage N., Badenhorst M., Whistler T. Acid maltase deficiency A case study and review of the pathophysiological changes and proposed therapeutic measures . J Neurol Neurosurg Psychiatry. 49:1986;1011-1018.
87. Slonim A.E., Coleman R.A., McElligot M.A., et al. Improvement of muscle function in acid maltase deficiency by high-protein therapy. Neurology. 33:1983;34-38.
88. Margolis M., Hill A. Acid maltase deficiency in an adult Evidence for improvement in respiratory function with high-protein dietary therapy . Am Rev Resp Dis. 134:1986;328-331.
89. Kikuchi T., Yang H.W., Pennybacker M., et al. Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail. J Clin Invest. 101:1998;827-833.
90. Nicolino M.P., Puech J.P., Kremer E.J., et al. Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation. Hum Mol Genet. 7:1998;1695-1702.
91. Treem W.R., Stanley C.A., Finegold D.N., Hale D.E., Coates P.M. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 319:1988;1331-1336.
92. Pons R., DeVivo D.C. Primary and secondary carnitine deficiency syndromes. J Child Neurol. 10:(Suppl):1995;2S8-224.
93. Engel A., Angelini C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy A new syndrome . Science. 179:1973;899-902.
94. Karpati G., Carpenter S., Engel A.G., et al. The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology. 25:1975;16-24.
95. Tripp M.E., Katcher M.L., Peters H.A., et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis A treatable cardiomyopathy . N Engl J Med. 305:1981;385-390.
96. Garavaglia B., Uziel G., Dworzak F., Carrara F., DiDonato S. Primary carnitine deficiency Heterozygote and intrafamilial phenotypic variation . Neurology. 41:1991;1691-1693.
97. Scholte H., de Jonge P. Metabolism, function and transport of carnitine in health and disease. Gitzelman R., Baerlocker K., Steinmann B. Carnitin in der Medizin. 1987;22-59 Schattauer, Stuttgart, Germany.
98. De Vivo D., Tein I. Primary and secondary disorders of carnitine metabolism. Int Pediatr. 5:1990;134-141.
99. Stanley C. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv Pediatr. 34:1987;59-88.
100. Engel A. Carnitine deficiency syndromes and lipid storage myopathies. Engel A., Banker B. Myology. 1986;1663-1696 McGraw-Hill, New York.
101. Shapira Y., Glick B., Harel S., Vattin J.J., Gutman A. Infantile idiopathic myopathic carnitine deficiency Treatment with L-carnitine . Pediatr Neurol. 9:1993;35-38.
102. Coates P., Hale D., Stanley C., Glasgow A. Systemic carnitine deficiency simulating Reye syndrome. J Pediatr. 105:1984;679.
103. Cruse R., DiMauro S., Towfighi J., Trevisan C. Familial systemic carnitine deficiency. Arch Neurol. 41:1984;301-305.
104. Hale D., Cruse R.P., Engel A.G. Familial systemic carnitine deficiency. Arch Neurol. 42:1985;1133.
105. Nezu J., Tamai I., Oku A., et al. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet. 21:1999;91-94.
106. Cornelio F., Di Donato S., Peluchetti D., et al. Fatal cases of lipid storage myopathy with carnitine deficiency. J Neurol Neurosurg Psychiatry. 40:1977;170-178.
107. Chapoy P.R., Angelini C., Brown W.J., Stiff J.E., Shug A.L., Cederbaum S.D. Systemic carnitine deficiency - a treatable inherited lipid-storage disease presenting as Reye's syndrome. N Engl J Med. 303:1980;1389-1394.
108. Pons R., Carrozzo R., Tein I., et al. Deficient muscle carnitine transport in primary carnitine deficiency. Pediatr Res. 42:1997;583-587.
109. Bernardini I., Rizzo W.B., Dalakas M., Bernar J., Gahl W.A. Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest. 75:1985;1124-1130.
110. Ito M., Ikeda Y., Arnez J.G., Finocchiaro G., Tanaka K. The enzymatic basis for the metabolism and inhibitory effects of valproic acid Dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase . Biochim Biophys Acta. 1034:1990;213-218.
111. Holme E., Greter J., Jacobson C. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1:1989;469-473.
112. Elpeleg O.N., Joseph A., Branski D., et al. Recurrent metabolic decompensation in profound carnitine palmitoyltransferase II deficiency. [see comments] J Pediatr. 122:1993;917-919.
113. Fontaine M., Briand G., Largilliere C., et al. Metabolic studies in a patient with severe carnitine palmitoyltransferase type II deficiency. Clin Chim Acta. 273:1998;161-170.
114. Poll-The B, Duran M, Mousson B, et al. Carnitine palmitoyltransferase I deficiency: Is there a diagnostic dicarboxylic aciduria? Proceedings of the 30th Annual Symposium of the Society for the Study of Inborn Errors of Metabolism. Lancaster, UK: Society for the Study of Inborn Errors of Metabolism, 1992:128 (abstract).
115. Stanley C., Hale D., Berry G., Deleeuw S., Boxer J., Bonnefont J.-P. Brief report A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane . N Engl J Med. 327:1992;19-22.
116. Chalmers R.A., Stanley C.A., English N., Wigglesworth J.S. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr. 131:1997;220-225.
117. Pande S. A mitochondrial carnitine acylcarnitine translocase system. Proc Natl Acad Sci U S A. 72:1975;883-887.
118. Falik-Borenstein Z.C., Jordan S.C., Saudubray J.M., et al. Brief report Renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency . N Engl J Med. 327:1992;24-27.
119. Gellera C., Verderio E., Floridia G., et al. Assignment of the human carnitine palmitoyltransferase II gene (CPTI) to chromosome 1p32. Genomics. 24:1994;195-197.
120. Britton C.H., Schultz R.A., Zhang B., Esser V., Foster D.W., McGarry J.D. Human liver mitochondrial carnitine palmitoyltransferase I Characterization of its cDNA and chromosomal localization and partial analysis of the gene . Proc Natl Acad Sci U S A. 92:1995;1984-1988.
121. Taroni F., Verderio E., Dworzak F., Willems P.J., Cavadini P., DiDonato S. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nat Genet. 4:1993;314-320.
122. Bonnefont J.-P., Taroni F., Cavadini P., et al. Molecular analysis of carnitine palitoyltransferase II deficiency with hepatocardiomuscular expression. Am J Hum Genet. 58:1996;971-978.
123. Taggart R.T., Smail D., Apolito C., Vladutiu G.D. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat. 13:1999;210-220.
124. Kaufmann P., el-Schahawi M., DiMauro S. Carnitine palmitoylstransferase II deficiency Diagnosis by molecular analysis of blood . Mol Cell Biochem. 174:1997;237-239.
125. DiMauro S., DiMauro P. Muscle carnitine palmitoyltransferase deficiency and myoglobinuria. Science. 182:1973;929-931.
126. DiMauro S., Papadimitriou A. Carnitine palmitoyltransferase deficiency. Engel A., Banker B. Myology. 1986;1697-1708 McGraw-Hill, New York.
127. Pierce M.R., Pridjian G., Morrison S., Pickoff A.S. Fatal carnitine palmitoylstransferase II deficiency in a newborn New phenotypic features . Clin Pediatr. 38:1999;13-20.
128. Demaugre F., Bonnefont J.P., Colonna M., Cepanec C., Leroux J.P., Saudubray J.M. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. J Clin Invest. 87:1991;859-864.
129. Hug G., Bove K., Soukup S. Lethal neonatal multi-organ deficiency of carnitine palmitoyltransferase II. N Engl J Med. 325:1991;1862-1864.
130. Hale D.E., Batshaw M.L., Coates P.M., et al. Long-chain acyl coenzyme A dehydrogenase deficiency An inherited cause of nonketotic hypoglycemia . Pediatr Res. 19:1985;666-671.
131. Engel W.K., Vick N.A., Glueck C.J., Levy R.I. A skeletal-muscle disorder associated with intermittent symptoms and a possible defect of lipid metabolism. N Engl J Med. 282:1970;697-704.
132. Stanley C.A., Hale D.E., Coates P.M., et al. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res. 17:1983;877-884.
133. Duran M., Hofkamp M., Rhead W.J., Saudubray J.M., Wadman S.K. Sudden child death and "healthy" affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics. 78:1986;1052-1057.
134. Amendt B.A., Greene C., Sweetman L., et al. Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest. 79:1987;1303-1309.
135. Tein I., De Vivo D.C., Hale D.E., et al. Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle A new cause for recurrent myoglobinuria and encephalopathy . Ann Neurol. 30:1991;415-419.
136. Tein I. Fatty acid oxidation and associated defects. 1995;9-38 Omnipress, Madison, WI.
137. Jackson S., Bartlett K., Land J., et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res. 29:1991;406-411.
138. Jackson S., Kler R.S., Bartlett K., et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest. 90:1992;1219-1225.
139. Schaefer J., Jackson S., Dick D., Turnbull D. Trifunctional enzyme deficiency Adult presentation of a usually fatal β-oxidation defect . Ann Neurol. 40:1996;597-602.
140. Sabina R.L., Morisaki T., Clarke P., et al. Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem. 265:1990;9423-9433.
141. Morisaki T., Gross M., Morisaki H., Pongratz D., Zollner N., Holmes E.W. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci U S A. 89:1992;6457-6461.
142. Sabina R.L., Holmes E.W. Myoadenylate deaminase deficiency. Schriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular basis of inherited diseases. 1995;1769-1780 McGraw-Hill, New York.
143. Fishbein W. Myoadenylate deaminase deficiency Inherited and acquired forms . Biochem Med. 33:1985;158-169.
144. Hyser C.L., Clarke P.R.H., DiMauro S., Mendell J.R. Myoadenylate deaminase deficiency and exertional myoglobinuria. (abstract) Neurology. 39:1989;335.
145. Fishbein W.N. Primary, secondary, and coincidental types of myoadenylate deaminase deficiency. (letter) Ann Neurol. 45:1999;547-548.
146. Verzijl H.T.F.M., van Engelen B.G.U., Luyten J.A.F.U., et al. Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol. 44:1998;140-143.
147. Fishbein W., Griffin J., Armbrustmacher V. Stain for skeletal muscle adenylate deaminase An effective tetrazolium stain for frozen biopsy specimens . Arch Pathol Lab Med. 104:1980;462-466.
148. Ogasahara S., Engel A.G., Frens D., Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A. 86:1989;2379-2392.
149. Saunier P., Chretien D., Wood C., et al. Cytochrome c oxidase deficiency presenting as recurrent neonatal myoglobinuria. Neuromuscul Disord. 5:1995;285-289.
150. Keightley J.A., Hoffbuhr K.C., Burton M.D., et al. A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nat Genet. 12:1996;410-416.
151. Chinnery P., Johnson M., Taylor R., Lightowlers R., Turnbull D. A novel mitochondrial tRNA phenylalanine mutation presenting with acute rhabdomyolysis. Ann Neurol. 41:1997;408-410.
152. Ohno K., Tanaka M., Sahashi K., et al. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol. 29:1991;364-369.
153. Andreu A.L., Bruno C., Dunne T.C., et al. A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol. 45:1999;127-130.
154. Andreu A.L., Hanna M.G., Reichmann H., et al. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med. 341:1999;1037-1044.